AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Scleroderma, Systemic

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site๐Ÿ“ Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: OL-108 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs) NCT07650565NA1 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Blood Sample Collection A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases NCT07284797Phase 11 site๐Ÿ“ Melbourne Xencor, Inc. ยท Tests: XmAb657 A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis NCT07047690Phase 23 sites๐Ÿ“ Ann Arbor๐Ÿ“ Arlington๐Ÿ“ Sankt Gallen Galderma R&D ยท Tests: Nemolizumab, Placebo Registry of Autoimmune Interstitial Lung Disease NCT05365009n/a1 site๐Ÿ“ Buenos Aires EPIMAR registry ยท Tests: Multidisciplinary aproach Platform Clinical Study for Conquering Scleroderma NCT06195072Phase 234 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Scleroderma Research Foundation, Inc. ยท Tests: Amlitelimab, BI 1015550 (Nerandomilast), Placebo Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis NCT06256575NA5 sites๐Ÿ“ Calgary๐Ÿ“ Halifax๐Ÿ“ London Primus Pharmaceuticals ยท Tests: Diosmin, Placebo Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site๐Ÿ“ Tianjin CytoCares Inc ยท Tests: CC312 Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate NCT06936215Phase 31 site๐Ÿ“ Dhaka Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladโ€ฆ ยท Tests: tab baricitinib 4 mg daily, tab methotrexate 25 mg weekly with folic acid 5 mg weekly Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders NCT06434363Phase 1, Phase 22 sites๐Ÿ“ Houston๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Tafasitamab, Fludarabine phosphate, Cyclophosphamide, Tafasitamab and NK cells A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease NCT07085104Phase 117 sites๐Ÿ“ Phoenix๐Ÿ“ Loma Linda๐Ÿ“ Aurora Allogene Therapeutics ยท Tests: ALLO-329, Cyclophosphamide, Fludarabine Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases NCT06732674NA1 site๐Ÿ“ Oslo Oslo University Hospital ยท Tests: A home monitoring strategy with event driven management Deployment o the Multidisciplinary Prospective Cohort Imminent NCT04334031NA1 site๐Ÿ“ Lille University Hospital, Lille ยท Tests: Biobanking with genetic analysis, SF-12 questionnaire A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721Phase 11 site๐Ÿ“ Hefei China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases NCT07301164EARLY Phase 11 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: BCT301 Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment NCT07691970Phase 3153 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ San Francisco AstraZeneca ยท Tests: Anifrolumab, Anifrolumab, Anifrolumab FT839 in Autoimmune Diseases NCT07800871Phase 1, Phase 21 site๐Ÿ“ Fullerton Fate Therapeutics ยท Tests: FT839 Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases NCT07121777NA1 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease NCT07723872n/a1 site๐Ÿ“ Granollers Hospital de Granollers ยท Tests: Dual-site pulse oximetry (finger and earlobe) Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis NCT05989763NA1 site๐Ÿ“ Houston The University of Texas Health Science Center, Houston ยท Tests: Transcutaneous Electrical Acustimulation (TEA), Sham-TEA Systemic Sclerosis DIet for GastrointESTinal Symptoms NCT07402226NA1 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: Diet 1: Restriction of fermentable carbohydrates, Diet 2: Elimination of foods harmful to gut barrier and microbiome, Dโ€ฆ A Study of ATG-201 in Adult Participants With Autoimmune Diseases NCT07732309Phase 122 sites๐Ÿ“ Bengbu๐Ÿ“ Hefei๐Ÿ“ Beijing Antengene Biologics Limited ยท Tests: ATG-201 Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies NCT04917705NA1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France ยท Tests: Collection of biological samples Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma. NCT04356755Phase 27 sites๐Ÿ“ Grenoble๐Ÿ“ Lille๐Ÿ“ Marseille University Hospital, Toulouse ยท Tests: AdMSC, Placebo The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life NCT06675344NA4 sites๐Ÿ“ New Orleans๐Ÿ“ Ann Arbor๐Ÿ“ Pittsburgh Robyn T. Domsic, MD, MPH ยท Tests: Apollo Neuro Device, Sham device A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases NCT07413341Phase 11 site๐Ÿ“ Shanghai Therorna ยท Tests: TI-0032-III injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy